Overview

The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)

Status:
Unknown status
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema
Phase:
Phase 4
Details
Lead Sponsor:
Texas Retina Associates
Collaborator:
The Emmes Company, LLC
Treatments:
Aflibercept
BB 1101
Dexamethasone
Dexamethasone acetate